School of Medicine - Clinical MedicineMedical Oncology




The Department of Medical Oncology was established on April 1, 2005. In clinical practice, we work at the Multidisciplinary Cancer Center, which was opened on October 1, 2005, the first tumor center in the Hokuriku District. We accept patients with various cancers such as breast, gastrointestinal, hematological, pancreato-biliary, and lung cancers. We see both out-patients and in-patients. In basic research, we are conducting molecular analysis on invasion and metastasis of cancer cells in collaboration with the INSERM U. 624 in Marseille, France, and other laboratories. We are in charge of oncology education, aiming at the comprehensive understanding of the pathophysiology of cancer and whole person care.

Contact Information

TEL: 076-286-2211 +81-76-286-2211  / FAX: 076-218-8283 +81-76-218-8283 / Email:


Professor and Chair

  • MOTOO Yoshiharu 元雄教授顔写真


  • YASUMOTO Kazuo

Senior Assistant Professor

  • HISAMURA Kazuho

Assistant Professor

  • KASAI Suguru

Research Achievements

Research Activities

  • Suzuki T, Yamamoto A, Ohsawa M, Motoo Y, Mizukami H, Makino T. Ninjin'yoeito and ginseng extract prevent oxaliplatin-induced neurodegeneration in PC12 cells. J Nat Med Oct; 69(4):531-7 2015.
  • Motoo Y, Arai I, Tsutani K. Use of Kampo diagnosis in randomized controlled trials of Kampo products in Japan: a systematic review. PLoS One, 9(8): e104422, 2014.
  • Efferth T, Lee S, Motoo Y, Schröder S. Acupuncture and herbal medicine for cancer patients 2014. Evid Based Complement Alternat Med, 2014, Article ID 326179, 2 pages.
  • Takata T, Motoo Y, Tomosugi N. Effect of Saikokeishito, a Kampo medicine, on hydrogen peroxide-induced premature senescence of normal human dermal fibroblasts. J Integr Med, 2014 Nov; 12(6): 495-503.
  • Kitano A, Shimasaki T, Chikano Y, Nakada M, Hirose M, Higashi T, Ishigaki Y, Endo Y, Takino T, Sato H, Sai Y, Miyamoto K, Motoo Y, Kawakami K, Minamoto T. Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy. PLoS One, 8(2):e55289, 2013.

External Research Funding

  • 2016-2018 Japan Agency for Medical Research and Development (AMED) Grant-in-Aid. Motoo Y.
    Objective evaluation of website of integrative medicine and systematic review of integrative medicine.
  • 2016-2018 Grant-in-Aid for Scientific Research (C). Motoo Y.
    Clinical efficacy and its molecular mechanisms of ninjinyoeito, a traditional Japanese medicine, on hematological and neurological toxicities of oxaliplatin.
  • 2017-2019 Grant-in-Aid for Exploratory Research. Hisamura K.
    Development of evaluation scale and screening intervention for social problems of cancer patients in working generations.
  • 2014-2016 Grant-in-Aid for Scientific Research (C). Yasumoto K.
    Essential clarification of the growth of cancerous stroma and the pathogenesis of carcinomatous peritonitis in schirrous gastric carcinoma.
  • 2010-2011 Health and Labor Sciences Research Grant. Motoo Y.
    Research on terminology, disease classification, devices, and safety of traditional medicine for ISO/TC249.